BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. Lung Cancer. 2005;49:345-351. [PMID: 15993511 DOI: 10.1016/j.lungcan.2005.05.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Makino H, Uetake H, Danenberg K, Danenberg PV, Sugihara K. Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. BMC Cancer 2008;8:210. [PMID: 18652704 DOI: 10.1186/1471-2407-8-210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
2 Muhale FA, Wetmore BA, Thomas RS, McLeod HL. Systems pharmacology assessment of the 5-fluorouracil pathway. Pharmacogenomics. 2011;12:341-350. [PMID: 21449674 DOI: 10.2217/pgs.10.188] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yoshitomi I, Kawasaki G, Yanamoto S, Mizuno A. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil. Oral Oncol 2006;42:880-7. [PMID: 16757204 DOI: 10.1016/j.oraloncology.2005.12.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
4 Kim SE, Hinoue T, Kim MS, Sohn KJ, Cho RC, Weisenberger DJ, Laird PW, Kim YI. Effects of folylpolyglutamate synthase modulation on global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells. J Nutr Biochem. 2016;29:27-35. [PMID: 26895662 DOI: 10.1016/j.jnutbio.2015.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dzobo K, Hassen N, Senthebane DA, Thomford NE, Rowe A, Shipanga H, Wonkam A, Parker MI, Mowla S, Dandara C. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe? Molecules 2018;23:E930. [PMID: 29673198 DOI: 10.3390/molecules23040930] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009;119:465-477. [PMID: 19221438 DOI: 10.1172/jci36460] [Cited by in Crossref: 244] [Cited by in F6Publishing: 144] [Article Influence: 20.3] [Reference Citation Analysis]
7 Khairullina VR, Gimadieva AR, Gerchikov AY, Mustafin AG, Zarudii FS. Quantitative structure-activity relationship of the thymidylate synthase inhibitors of Mus musculus in the series of quinazolin-4-one and quinazolin-4-imine derivatives. J Mol Graph Model 2018;85:198-211. [PMID: 30227365 DOI: 10.1016/j.jmgm.2018.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Lee BR, Yu JY, Yoon SH, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC. Variability in the anti-tumor effect of tegafur-uracil depending on histologic types of lung cancer. J Thorac Dis 2015;7:433-8. [PMID: 25922722 DOI: 10.3978/j.issn.2072-1439.2015.01.22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Refaat A, Aminullah, Zhou Y, Kawanishi M, Tomaru R, Abdelhamed S, Shin M, Koizumi K, Yokoyama S, Saiki I, Sakurai H. Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells. Biochemical and Biophysical Research Communications 2015;458:856-61. [DOI: 10.1016/j.bbrc.2015.02.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Takakuwa O, Oguri T, Maeno K, Ozasa H, Iwashima Y, Miyazaki M, Kunii H, Takano Y, Mori T, Sato S, Ueda R. Efficacy of S-1 monotherapy for non-small cell lung cancer after the failure of two or more prior chemotherapy regimens. Oncol Lett 2010;1:147-50. [PMID: 22966273 DOI: 10.3892/ol_00000027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Zhao HY, Chen GY, Huang Y, Li XL, Feng JF, Shi MQ, Cheng Y, Ma LX, Zhang YP, Gu CP, Song XQ, Zhou D, Zhang L. Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study. Medicine (Baltimore) 2015;94:e249. [PMID: 25590835 DOI: 10.1097/MD.0000000000000249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Ozasa H, Oguri T, Uemura T, Miyazaki M, Maeno K, Sato S, Ueda R. Significance of thymidylate synthase for resistance to pemetrexed in lung cancer. Cancer Sci. 2010;101:161-166. [PMID: 19811498 DOI: 10.1111/j.1349-7006.2009.01358.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
13 Yasumatsu R, Nakashima T, Uryu H, Masuda M, Hirakawa N, Shiratsuchi H, Tomita K, Fukushima M, Komune S. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells. Oral Oncology 2009;45:141-7. [DOI: 10.1016/j.oraloncology.2008.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Jiao D, Yan Y, Shui S, Wu G, Ren J, Wang Y, Han X. miR-106b regulates the 5-fluorouracil resistance by targeting Zbtb7a in cholangiocarcinoma. Oncotarget 2017;8:52913-22. [PMID: 28881782 DOI: 10.18632/oncotarget.17577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kucerova L, Feketeova L, Kozovska Z, Poturnajova M, Matuskova M, Nencka R, Babal P. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset. Thyroid 2014;24:520-32. [PMID: 24073856 DOI: 10.1089/thy.2013.0277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang CL, Yokomise H, Fukushima M, Kinoshita M. Tailor-made chemotherapy for non-small cell lung cancer patients. Future Oncol 2006;2:289-99. [PMID: 16563096 DOI: 10.2217/14796694.2.2.289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
17 Okuda K, Tatematsu T, Yano M, Nakamae K, Yamada T, Kasugai T, Nishida T, Sano M, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R. The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancer. Mol Clin Oncol 2018;9:21-9. [PMID: 29977535 DOI: 10.3892/mco.2018.1619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ishihama H, Chida M, Araki O, Karube Y, Seki N, Tamura M, Umezu H, Honma K, Masawa N, Miyoshi S. Comparison of 5-Fluorouracil-related Gene Expression Levels Between Adenocarcinomas and Squamous Cell Carcinomas of the Lung. Japanese Journal of Clinical Oncology 2008;39:33-6. [DOI: 10.1093/jjco/hyn121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
19 Majumder S, Muley A, Kolluru GK, Saurabh S, Tamilarasan KP, Chandrasekhar S, Reddy HB, Purohit S, Chatterjee S. Cadmium reduces nitric oxide production by impairing phosphorylation of endothelial nitric oxide synthase. Biochem Cell Biol 2008;86:1-10. [DOI: 10.1139/o07-146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 8] [Article Influence: 3.1] [Reference Citation Analysis]
20 Minegaki T, Suzuki A, Mori M, Tsuji S, Yamamoto S, Watanabe A, Tsuzuki T, Tsunoda T, Yamamoto A, Tsujimoto M, Nishiguchi K. Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil. Oncol Lett 2018;16:6202-8. [PMID: 30333885 DOI: 10.3892/ol.2018.9388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Kachalaki S, Ebrahimi M, Mohamed Khosroshahi L, Mohammadinejad S, Baradaran B. Cancer chemoresistance; biochemical and molecular aspects: a brief overview. Eur J Pharm Sci 2016;89:20-30. [PMID: 27094906 DOI: 10.1016/j.ejps.2016.03.025] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 16.0] [Reference Citation Analysis]
22 Chen S, Sun J, Zhao L, Sun Y, Jia D, Song Y, Luo J, Lei H, Liu N. Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment. Exp Ther Med 2021;21:62. [PMID: 33365062 DOI: 10.3892/etm.2020.9494] [Reference Citation Analysis]
23 Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, Forcier T, Shah K, Saxena U, Hansen U, Fisher PB, Sarkar D. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A. 2009;106:12938-12943. [PMID: 19622726 DOI: 10.1073/pnas.0901451106] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
24 Kim SE, Hinoue T, Kim MS, Sohn KJ, Cho RC, Cole PD, Weisenberger DJ, Laird PW, Kim YI. γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells. Genes Nutr 2015;10:444. [PMID: 25502219 DOI: 10.1007/s12263-014-0444-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
25 Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. World J Gastroenterol 2012;18:3955-61. [PMID: 22912546 DOI: 10.3748/wjg.v18.i30.3955] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
26 Sanada Y, Yoshida K, Ohara M, Tsutani Y. Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma. Pathol Oncol Res 2007;13:105-13. [DOI: 10.1007/bf02893485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Uemura T, Oguri T, Maeno K, Sone K, Takeuchi A, Fukuda S, Kunii E, Takakuwa O, Kanemitsu Y, Ohkubo H, Takemura M, Ito Y, Niimi A. ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer. Cancer Chemother Pharmacol 2019;84:1229-39. [DOI: 10.1007/s00280-019-03959-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tomita Y, Oguri T, Takakuwa O, Nakao M, Kunii E, Uemura T, Ozasa H, Miyazaki M, Maeno K, Sato S. S-1 monotherapy for previously treated non-small cell lung cancer: A retrospective analysis by age and histopathological type. Oncol Lett 2012;3:405-10. [PMID: 22740921 DOI: 10.3892/ol.2011.507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Ibe T, Shimizu K, Nakano T, Kakegawa S, Kamiyoshihara M, Nakajima T, Kaira K, Takeyoshi I. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes. J Surg Oncol 2010;102:11-7. [PMID: 20578072 DOI: 10.1002/jso.21576] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
30 Takezawa K, Okamoto I, Tsukioka S, Uchida J, Kiniwa M, Fukuoka M, Nakagawa K. Identification of thymidylate synthase as a potential therapeutic target for lung cancer. Br J Cancer 2010;103:354-61. [PMID: 20628382 DOI: 10.1038/sj.bjc.6605793] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
31 Hamaguchi J, Nakagawa H, Takahashi M, Kudo T, Kamiyama N, Sun B, Oshima T, Sato Y, Deguchi K, Todo S, Nishimura S. Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines. Mol Cancer 2007;6:58. [PMID: 17883871 DOI: 10.1186/1476-4598-6-58] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
32 Sarkar D. AEG-1/MTDH/LYRIC in liver cancer. Adv Cancer Res 2013;120:193-221. [PMID: 23889992 DOI: 10.1016/B978-0-12-401676-7.00007-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
33 Nadkar A, Pungaliya C, Drake K, Zajac E, Singhal SS, Awasthi S. Therapeutic resistance in lung cancer. Expert Opinion on Drug Metabolism & Toxicology 2006;2:753-77. [DOI: 10.1517/17425255.2.5.753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
34 Oguri T, Achiwa H, Muramatsu H, Ozasa H, Sato S, Shimizu S, Yamazaki H, Eimoto T, Ueda R. The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer. Cancer Lett 2007;256:112-9. [PMID: 17658213 DOI: 10.1016/j.canlet.2007.06.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]